Clinical Trials Logo

Peripheral Arterial Disease clinical trials

View clinical trials related to Peripheral Arterial Disease.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06436001 Completed - Diabetes Mellitus Clinical Trials

Comparing BlueDop Vascular Expert to Ankle-Brachial Index in the Identification of Peripheral Vascular Disease

Start date: March 1, 2023
Phase:
Study type: Observational

To compare the screening capabilities of the BlueDop Vascular Expert (BVE) and ankle brachial index (ABI) in peripheral arterial disease for all-comer patients and those with diagnosed diabetes mellitus.

NCT ID: NCT06234280 Completed - Clinical trials for Moderate or Severe Claudication (Rutherford Category 2 or 3)

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease

K-ELUVIA
Start date: May 11, 2018
Phase:
Study type: Observational

- Prospective, multi-center single-arm observational study - A total of 100 subjects with femoropopliteal artery disease who meet all inclusion and exclusion criteria will be included. - Patients will be followed clinically for 24 months after the procedure. - An imaging study (duplex ultrasound, CT or catheter-based angiography) follow-up according to participating hospital's protocol will be performed at 12 months. - Ankle-brachial index, symptom status and presence of stent fracture will be evaluated at 12 months.

NCT ID: NCT06173960 Completed - Clinical trials for Peripheral Artery Disease

3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions

FIDJI
Start date: November 3, 2023
Phase:
Study type: Observational

The goal of this non interventional study is to evaluate the long-term clinical effects (3-year follow-up after the procedure) of Jetstream atherectomy combined with a paclitaxel-eluting balloon (Ranger) in all patients who were treated for calcified femoropopliteal lesions (de novo, single or multiple, mono- or bilateral) between December 1, 2016 and December 31, 2020 at the Clinique Rhône-Durance, Avignon, France

NCT ID: NCT06020534 Completed - Clinical trials for Peripheral Arterial Disease

Aortoiliac Stenosis in Kidney Transplantation

TASC
Start date: January 1, 2022
Phase:
Study type: Observational

The impact of aortoiliac stenosis on kidney transplant patients remains unclear. This study aims to investigate the safety and efficacy of kidney transplantation in patients with aortoiliac stenosis.

NCT ID: NCT05921461 Completed - Diabetes Mellitus Clinical Trials

The Use of HOVR Technology for Assessment of Blood Associated Parameters

Start date: May 1, 2022
Phase:
Study type: Observational

Feasibility, usability and safety clinical study that is aimed at testing of the non-invasive VOTIS PedCheck system for measurement of changes in absorption of light in order to derive changes in perfusion and oxygen levels in the foot.

NCT ID: NCT05881421 Completed - Clinical trials for Peripheral Arterial Disease

DISRUPT PAD III Observational Study

PAD III OS
Start date: November 16, 2017
Phase:
Study type: Observational [Patient Registry]

The Disrupt PAD III study was designed as a randomized controlled trial (RCT) with an additional observational registry component. The registry, referred to as the Disrupt PAD III Observational Study (PAD III OS), was a global, prospective, multi-center, single-arm registry of the Shockwave Peripheral Intravascular Lithotripsy (IVL) System. The objective of this study was to assess the real-world acute performance of IVL in the treatment of calcified, stenotic, peripheral arteries that may not qualify for inclusion in the RCT. The study was designed to enroll a maximum of 1500 subjects from up to 60 global sites with a minimum of 200 subjects treated with the S4 IVL catheter, a line extension designed to treat smaller diameter peripheral vessels, including calcified below-the-knee (BTK) lesions. Subjects were required to have target lesions in the iliac, femoral, ilio-femoral, popliteal, or infra-popliteal arteries with at least moderate calcification as determined by the investigator, defined as calcification within the lesion on both sides of the vessel assessed by angiography. Adjunctive therapies such as atherectomy, specialty balloons, and stents were allowed. Subjects were followed through discharge.

NCT ID: NCT05837442 Completed - Clinical trials for Peripheral Arterial Disease

The Effect Of Osteopathic Manual Therapy On Arterial Circulation In Patients With Peripheral Arterial Disease

Start date: May 1, 2017
Phase: N/A
Study type: Interventional

Peripheral artery disease (PAD) is a chronic atherosclerotic process that causes narrowing of peripheral arterial vessels in the lower extremities. Osteopathic manual therapy (OMT) is one of the new treatment options for various pathologies. The aim of this study was to investigate the effect of OMT on arterial circulation in patients with PAD.

NCT ID: NCT05822960 Completed - Clinical trials for Peripheral Arterial Disease

To Investigate the Effect of Far-infrared Radiation on Lower Extremity Acupoints on the Blood Circulation of Lower Extremities in Patients With Hemodialysis

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

This study intends to irradiate the acupoints of both lower extremities of hemodialysis patients with far-infrared therapeutic apparatus to explore its effect on foot blood circulation, peripheral artery occlusion disease (PAOD) symptoms and ankle-brachial index (Ankle-Brachial Index, ABI) value.

NCT ID: NCT05752968 Completed - Clinical trials for Peripheral Arterial Disease

Elevated Levels of Antibodies to Endotoxin Core in Hemodialysis Patients With Peripheral Artery Disease

Start date: May 3, 2023
Phase:
Study type: Observational

Background Peripheral arterial disease (PAD) and its relevant complications are more common in hemodialysis (HD) patients. The potential association regarding chronic kidney disease dysbiosis, inflammation and metabolic endotoxinemia in HD patients is unknown. A cross-sectional study will be carried out the evaluate the possible association endotoxin core antibody with asymptomatic PAD in a cohort of HD patients. Methods This cohort study enrolled 500 HD patients treated at a single center in Taichung city. Fasting blood samples will be collected to determine biochemical data Endotoxin core antibody levels and other related biomarkers. By the automatic oscillometric method, the ankle-brachial index (ABI) was measured. Low ABI was defined as any value < 0.9.

NCT ID: NCT05747287 Completed - Clinical trials for Coronary Artery Disease

Evaluate Safety and Efficacy of Pronavi Microcatheter for Use in Endovascular Interventions

Start date: January 17, 2023
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, single-group post-market study. It is planned to be carried out in about 3 clinical institutions, and a total of 60 subjects are expected to be enrolled.